Townsquare Capital LLC Purchases 109,217 Shares of Haleon plc (NYSE:HLN)

Townsquare Capital LLC increased its holdings in Haleon plc (NYSE:HLN) by 29.8% during the third quarter, HoldingsChannel reports. The institutional investor owned 475,618 shares of the company’s stock after acquiring an additional 109,217 shares during the quarter. Townsquare Capital LLC’s holdings in Haleon were worth $5,032,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in HLN. Fortitude Family Office LLC purchased a new stake in shares of Haleon in the 3rd quarter valued at about $28,000. Cultivar Capital Inc. bought a new position in shares of Haleon in the second quarter worth approximately $40,000. Hexagon Capital Partners LLC raised its stake in Haleon by 66.6% in the second quarter. Hexagon Capital Partners LLC now owns 6,695 shares of the company’s stock valued at $55,000 after purchasing an additional 2,677 shares in the last quarter. Prospera Private Wealth LLC bought a new stake in Haleon during the third quarter valued at approximately $57,000. Finally, BOKF NA grew its stake in Haleon by 68.8% in the 2nd quarter. BOKF NA now owns 6,972 shares of the company’s stock worth $58,000 after buying an additional 2,842 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.

Wall Street Analyst Weigh In

HLN has been the topic of several research reports. UBS Group upgraded shares of Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. Morgan Stanley raised their price target on Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a research report on Friday, September 20th. The Goldman Sachs Group cut Haleon from a “buy” rating to a “neutral” rating in a report on Tuesday, August 6th. Finally, Berenberg Bank began coverage on Haleon in a report on Tuesday, August 6th. They set a “buy” rating on the stock. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $10.95.

Haleon Price Performance

Shares of NYSE:HLN opened at $9.72 on Friday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The stock has a market cap of $44.00 billion, a PE ratio of 28.59, a PEG ratio of 2.89 and a beta of 0.30. The company’s fifty day moving average is $9.95 and its 200 day moving average is $9.41. Haleon plc has a 52 week low of $7.89 and a 52 week high of $10.80.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.